Literature DB >> 31711753

Core inhibitor therapy for chronic hepatitis B.

Milan J Sonneveld1.   

Abstract

Entities:  

Year:  2019        PMID： 31711753     DOI： 10.1016/S2468-1253(19)30325-5

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


× No keyword cloud information.
  1 in total

1.  Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen loss.

Authors:  Sylvia M Brakenhoff; Robert A de Man; André Boonstra; Margo J H van Campenhout; Robert J de Knegt; Florian van Bömmel; Annemiek A van der Eijk; Thomas Berg; Bettina E Hansen; Harry L A Janssen; Milan J Sonneveld
Journal:  Aliment Pharmacol Ther       Date:  2020-11-21       Impact factor: 8.171
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.